180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla

Core Viewpoint - 180 Life Sciences Corp. plans to raise $425 million through a PIPE funding to adopt a treasury policy focused on Ether (ETH) and will rebrand as ETHZilla Corporation [1][16]. Transaction Overview - The PIPE transaction involves approximately $425 million for the purchase and sale of common stock, expected to close around August 1, 2025, subject to customary conditions [2]. - The company has approval to sell up to $150 million in debt securities following the PIPE closing [2]. Use of Proceeds - Net proceeds from the offering will primarily be used for purchasing ETH, general corporate purposes, and transaction expenses [3]. Investor Participation - Over 60 institutional and crypto-native investors are participating in the PIPE transaction, including notable figures from the Ethereum ecosystem [4]. Market Context - The Ethereum network has a market cap exceeding $450 billion, positioning it among the most valuable companies globally [5]. Strategic Goals - The company aims to provide investors with exposure to a high-yield potential ecosystem central to stablecoin and tokenized asset markets [5]. - Electric Capital will act as the external asset manager, implementing a differentiated yield generation program designed to outperform traditional ETH staking [5][17]. Long-term Vision - The company intends to execute a long-term investment strategy focused on acquiring ETH and generating yield from its ETH treasury [7]. - ETHZilla aims to be a community-driven ETH accumulation vehicle, facilitating investor access to the Ethereum network [17]. Partnerships and Advisory - The company plans to collaborate with Etherealize and a DeFi Council composed of leading DeFi builders to optimize treasury yield generation [8][9].